TOBRAMYCIN AND DEXAMETHASONE Drug Patent Profile
✉ Email this page to a colleague
When do Tobramycin And Dexamethasone patents expire, and what generic alternatives are available?
Tobramycin And Dexamethasone is a drug marketed by Amneal, Bausch And Lomb, and Padagis Us. and is included in three NDAs.
The generic ingredient in TOBRAMYCIN AND DEXAMETHASONE is dexamethasone; tobramycin. There are thirty-nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the dexamethasone; tobramycin profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TOBRAMYCIN AND DEXAMETHASONE?
- What are the global sales for TOBRAMYCIN AND DEXAMETHASONE?
- What is Average Wholesale Price for TOBRAMYCIN AND DEXAMETHASONE?
Summary for TOBRAMYCIN AND DEXAMETHASONE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 3 |
| Clinical Trials: | 15 |
| What excipients (inactive ingredients) are in TOBRAMYCIN AND DEXAMETHASONE? | TOBRAMYCIN AND DEXAMETHASONE excipients list |
| DailyMed Link: | TOBRAMYCIN AND DEXAMETHASONE at DailyMed |
Recent Clinical Trials for TOBRAMYCIN AND DEXAMETHASONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tianjin Medical University Eye Hospital | Phase 1 |
| Sutphin Drugs | Early Phase 1 |
| University Hospital Fattouma Bourguiba | Phase 4 |
Pharmacology for TOBRAMYCIN AND DEXAMETHASONE
| Drug Class | Aminoglycoside Antibacterial Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for TOBRAMYCIN AND DEXAMETHASONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal | TOBRAMYCIN AND DEXAMETHASONE | dexamethasone; tobramycin | SUSPENSION/DROPS;OPHTHALMIC | 212991-001 | Jul 15, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bausch And Lomb | TOBRAMYCIN AND DEXAMETHASONE | dexamethasone; tobramycin | SUSPENSION/DROPS;OPHTHALMIC | 064134-001 | Oct 27, 1999 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Padagis Us | TOBRAMYCIN AND DEXAMETHASONE | dexamethasone; tobramycin | SUSPENSION/DROPS;OPHTHALMIC | 212715-001 | Feb 11, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
